Latest Shareholder Participation News

Future Metals NL has announced a partially underwritten entitlement offer aiming to raise approximately AUD 2.64 million to support development of its Eileen Bore Project and working capital needs. The offer opens to eligible shareholders on 15 May 2025 and closes on 30 May 2025.

MedAdvisor Limited has successfully closed its Share Purchase Plan, raising $2.668 million—exceeding its $2 million target—and plans an upcoming shareholder meeting to approve director share issuances.

Terrain Minerals Ltd has announced a pro-rata entitlement offer to raise up to $1.82 million, supported by partial underwriting from directors Justin Virgin and Jason MacDonald. The capital raise aims to fund key exploration activities at the Smokebush Project and other initiatives.

Bio-Gene Technology Limited has launched a Share Purchase Plan allowing Australian shareholders to invest up to $15,000 at 2.3 cents per share, matching a recent $2.1 million placement. The offer includes free-attaching options, subject to shareholder approval, to support key product development milestones.

Metgasco Ltd has announced a partially underwritten entitlement offer to raise up to $750,000, aiming to fund a production uplift program at its Odin and Vali gas fields. The capital raise targets near-term gas flow improvements and enhanced cash generation.

Macquarie Group Limited has announced a fully franked ordinary dividend of AUD 3.90 per share for the half-year ending March 2025, accompanied by a dividend reinvestment plan with no discount.

Sparc Technologies has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a 28.6% discount, aiming to raise up to $500,000 to fund key growth initiatives.

Western Yilgarn Limited has successfully closed its non-renounceable Entitlement and Priority Option Offers, raising nearly A$54,000 through the issue of new options to shareholders.

Future Metals NL has announced a $2.64 million entitlement offer to fund its Eileen Bore Cu-Ni-PGM project, partially underwritten by CPS Capital Group. The offer opens mid-May to eligible shareholders across multiple jurisdictions.

Mirrabooka Investments Limited has launched a $85 million non-renounceable entitlement offer at $3.06 per share, inviting eligible shareholders to increase their holdings with a top-up facility. The offer aims to bolster the company’s investment capacity amid evolving market conditions.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.

Saturn Metals has significantly upsized its Share Purchase Plan to $9.25 million, raising total capital of $32.25 million to accelerate development of its Apollo Hill Gold Project and expand exploration in Western Australia.